Brooks Laboratories Schedules Board Meeting on 7th Nov'26 for Q2 Financial Results
Brooks Laboratories Ltd 路 Intimation 路 07 Nov 2026, 5:30 am
Brooks Laboratories Schedules Board Meeting on 7th Nov'26 for Q2 Financial Results Brooks Laboratories Limited announced that its Board of Directors will meet on 7th Nov'26 to consider and approve the unaudited standalone and consolidated financial results, along with the Limited Review Report, for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in company securities, closed since 1st Oct'26 for designated persons and insiders, will reopen 48 hours after the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Brooks Laboratories Ltd
- Intimation of upgrade in Credit Rating 路 12 Nov 2026
- Financial Results for the quarter and half year ended September 30, 2026 路 07 Nov 2026
- Financial Results for the quarter and half year ended September 30, 2026 路 07 Nov 2026
- Brooks Laboratories Limited has submitted to the Exchange, the financial results for the quarter and half year ended September 30, 2026. 路 07 Nov 2026
- Financial Results for the quarter and half year ended September 30, 2026 路 07 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 07 Nov 2026
- Brooks Laboratories Limited has informed the BSE that the meeting of Board of Directors of the Company is scheduled on 07/11/2026, inter alia, to consider and approve take on records the .... 路 03 Nov 2026
- BROOKS LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 07-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 07 Nov 2026
